Learning Where to See: A Novel Attention Model for Automated Immunohistochemical Scoring

TL;DR

This paper introduces a deep reinforcement learning model for automated HER2 IHC scoring in breast cancer, efficiently identifying relevant regions in large histology images, outperforming existing methods, and pioneering DRL application in computational pathology.

Contribution

The study presents the first use of deep reinforcement learning for IHC scoring, enabling targeted analysis of histology images and reducing computational costs.

Findings

Outperforms state-of-the-art deep convolutional network methods.

Effectively identifies diagnostically relevant regions in large images.

Reduces computational burden in histopathology analysis.

Abstract

Estimating over-amplification of human epidermal growth factor receptor 2 (HER2) on invasive breast cancer (BC) is regarded as a significant predictive and prognostic marker. We propose a novel deep reinforcement learning (DRL) based model that treats immunohistochemical (IHC) scoring of HER2 as a sequential learning task. For a given image tile sampled from multi-resolution giga-pixel whole slide image (WSI), the model learns to sequentially identify some of the diagnostically relevant regions of interest (ROIs) by following a parameterized policy. The selected ROIs are processed by recurrent and residual convolution networks to learn the discriminative features for different HER2 scores and predict the next location, without requiring to process all the sub-image patches of a given tile for predicting the HER2 score, mimicking the histopathologist who would not usually analyze every part of the slide at the highest magnification. The proposed model incorporates a task-specific regularization term and inhibition of return mechanism to prevent the model from revisiting the previously attended locations. We evaluated our model on two IHC datasets: a publicly available dataset from the HER2 scoring challenge contest and another dataset consisting of WSIs of gastroenteropancreatic neuroendocrine tumor sections stained with Glo1 marker. We demonstrate that the proposed model outperforms other methods based on state-of-the-art deep convolutional networks. To the best of our knowledge, this is the first study using DRL for IHC scoring and could potentially lead to wider use of DRL in the domain of computational pathology reducing the computational burden of the analysis of large multigigapixel histology images.